|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 676.23 USD | +4.07% |
|
+8.45% | -12.39% |
| Market Cap | 68.8B 60.21B 55.49B 51.43B 97.63B 6,530B 99.2B 665B 259B 3,223B 258B 253B 11,138B | P/E 2026 * |
17.5x | P/E 2027 * | 14.1x |
|---|---|---|---|---|---|
| Enterprise Value | 60.97B 53.35B 49.17B 45.57B 86.51B 5,786B 87.91B 590B 229B 2,856B 229B 224B 9,870B | EV / Sales 2026 * |
3.84x | EV / Sales 2027 * | 3.32x |
| Free-Float |
72.33% | Yield 2026 * |
0.58% | Yield 2027 * | 0.66% |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | +4.07% | ||
| 1 week | +8.45% | ||
| Current month | +8.45% | ||
| 1 month | +6.42% | ||
| 3 months | -11.05% | ||
| 6 months | -16.75% | ||
| Current year | -12.39% |
| 1 week | 625.7 |  | 677.92 |
| 1 month | 594.9 | | 677.92 |
| Current year | 591.52 | | 821.11 |
| 1 year | 541 | | 821.11 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 31/12/2000 | |
| Chief Executive Officer | 73 | 07/01/1988 | |
| Director of Finance/CFO | 55 | 04/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 08/06/2023 | |
Michael Brown
BRD | Director/Board Member | 85 | 31/05/1991 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 31/05/1991 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-30 | Sell | Director | -100 | 0.0001% | ||
| 03-31 | Sell | Director | 100 | 0.0001% | ||
| 03-01 | Sell | Director | 100 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.07% | +8.45% | +25.67% | -2.34% | 68.8B | |
| -0.24% | -3.13% | +49.38% | +223.97% | 55.21B | |
| +1.21% | +42.20% | +42.20% | +42.20% | 43.46B | |
| +0.27% | +8.33% | -49.87% | -53.43% | 41.18B | |
| -2.48% | +13.91% | +166.79% | -32.89% | 31.65B | |
| -1.32% | -4.79% | +58.07% | -25.22% | 30.37B | |
| +2.10% | +4.14% | +75.49% | +90.19% | 23.58B | |
| -0.63% | +8.79% | +4.91% | +186.28% | 19.33B | |
| -0.04% | +3.85% | +67.76% | +135.89% | 17.16B | |
| +0.21% | +4.61% | +79.10% | +361.28% | 15.27B | |
| Average | +0.31% | +4.32% | +51.95% | +92.59% | 34.6B | |
| Weighted average by Cap. | +0.72% | +4.21% | +44.97% | +68.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15.88B 13.9B 12.81B 11.87B 22.54B 1,507B 22.9B 154B 59.73B 744B 59.62B 58.33B 2,571B | 17.56B 15.37B 14.16B 13.13B 24.92B 1,667B 25.32B 170B 66.05B 823B 65.93B 64.51B 2,843B |
| Net income | 4.09B 3.58B 3.3B 3.06B 5.8B 388B 5.9B 39.54B 15.38B 191B 15.35B 15.02B 662B | 5.13B 4.49B 4.14B 3.84B 7.28B 487B 7.4B 49.64B 19.31B 240B 19.27B 18.85B 831B |
| Net Debt | -7.83B -6.86B -6.32B -5.86B -11.12B -743B -11.3B -75.76B -29.46B -367B -29.41B -28.77B -1,268B | -10.5B -9.19B -8.47B -7.85B -14.9B -997B -15.14B -102B -39.49B -492B -39.43B -38.57B -1,700B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/07/26 | US$676.23 | +4.07% | 918,937 |
| 06/07/26 | US$649.81 | -0.68% | 714,338 |
| 02/07/26 | US$654.27 | +4.73% | 1,071,604 |
| 01/07/26 | US$624.72 | +0.19% | 1,170,657 |
| 30/06/26 | US$623.54 | -1.31% | 820,925 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
